Each ml contains Ibandronate Sodium Monohydrate 1.125mg
(eq. to Ibandronate 1mg)
Strength
3 ml
Package Size
1 Vial/Box
Product Code
B0NVI020003
NHI. NO.
AC58345216
Marketing Status
prescription drug
Indications
It is used to treat osteoporosis in postmenopausal women (BMD T SCORE <-2.5 SD) to reduce vertebral fractures.
Dosage Initial & maintenance dose
Ibandronate Inj.is administered every 3 months, and intravenous injection is slow for at least 15 seconds. Patients must supplement calcium and vitamin D3.
